Morgan Stanley initiated coverage on IsoPlexis with a new price target
$ISO
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Morgan Stanley initiated coverage of IsoPlexis with a rating of Overweight and set a new price target of $16.00